Literature DB >> 1720114

Consideration on two cases of dystonia-parkinsonism.

C A Zambrino1, U Balottin, R Borgatti, G Lanzi.   

Abstract

We describe two sporadic cases of dystonia-parkinsonism at different stages of disease progression. The two girls, first seen at the ages of 10 and 12 years, have been followed for 9 and 2 years respectively. In both patients L-dopa 60 mg + carbidopa 6 mg brought about a swift remission of symptoms, which persists to date. All examinations, including CT and MR brainscans, were normal. The CSF and urine levels of HVA and 5HIAA were low in one case and normalized with treatment. This finding might provide a fairly valid predictive index of responsiveness to L-dopa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720114     DOI: 10.1007/bf02335509

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  12 in total

1.  Kinetic study of catecholamine metabolism in hereditary progressive dystonia.

Authors:  A P de Jong; E A Haan; J I Manson; G A Wise; R A Ouvrier; S K Wadman
Journal:  Neuropediatrics       Date:  1989-02       Impact factor: 1.947

2.  Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.

Authors:  M Yokochi; H Narabayashi; R Iizuka; T Nagatsu
Journal:  Adv Neurol       Date:  1984

3.  [Description of a case of dystonia musculorum deformans treated with L-dopa].

Authors:  U Balottin; G Lanzi; C A Zambrino
Journal:  Riv Neurobiol       Date:  1981 Jul-Dec

4.  Oestrogens and extrapyramidal system.

Authors:  P Bedard; P Langelier; A Villeneuve
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

5.  Hereditary dystonia-parkinsonism syndrome of juvenile onset.

Authors:  T G Nygaard; R C Duvoisin
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

6.  Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine.

Authors:  B P Garg
Journal:  Arch Neurol       Date:  1982-06

7.  Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.

Authors:  N Sunohara; Y Mano; K Ando; E Satoyoshi
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

8.  Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

Authors:  G M Halliday; Y W Li; P C Blumbergs; T H Joh; R G Cotton; P R Howe; W W Blessing; L B Geffen
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

9.  DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms--Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS).

Authors:  T Deonna
Journal:  Neuropediatrics       Date:  1986-05       Impact factor: 1.947

10.  Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.

Authors:  J Willemse; O van Nieuwenhuizen; R H Gooskens; H G Westenberg
Journal:  Neuropediatrics       Date:  1984-10       Impact factor: 1.947

View more
  2 in total

1.  Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.

Authors:  M Naumann; M Götz; K Reiners; K W Lange; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients.

Authors:  Elze R Timmers; Débora E Peretti; Marenka Smit; Bauke M de Jong; Rudi A J O Dierckx; Anouk Kuiper; Tom J de Koning; David Vállez García; Marina A J Tijssen
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.